| Journal of Drugs in Dermatology | |
| Abbreviation: | J. Drugs Dermatol. |
| Discipline: | Dermatology |
| Language: | English |
| Editors: | Perry Robins Deborah S. Sarnoff |
| Publisher: | SanovaWorks |
| Country: | USA |
| History: | 2002–present |
| Frequency: | Monthly |
| Impact: | 1.464 |
| Impact-Year: | 2019 |
| Issn: | 1545-9616 |
| Website: | https://jddonline.com/ |
| Link1: | https://jddonline.com/supplement_library |
| Link1-Name: | Supplement library |
| Link2: | https://jddonline.com/cme#/ |
| Link5: | --> |
| Link2-Name: | CME offerings |
| Link5-Name: | --> |
The Journal of Drugs in Dermatology is a monthly peer-reviewed medical journal of dermatology published by Sanovaworks. The journal was established in 2002 by Mohs surgeon Perry Robins, founder of the Skin Cancer Foundation. It is the flagship publication of Sanovaworks, publisher of Derm-in-Review and Next Steps, as well as the sponsor of JDD Podcasts and two annual medical specialty conferences, Skin of Color Update (SOCU), and the ODAC Dermatology Aesthetic and Surgical (ODAC) conferences.
The following persons have been co-editor-in-chief of the journal:
The journal is abstracted and indexed in the following bibliographic databases:[1]
The journal was accepted into the Science Citation Index[5] in 2003 and received an impact factor in 2004.[6] According to the Journal Citation Reports, the journal has a 2019 impact factor of 1.464.[7]